Physician profile
John Stephen Lutz
NPI 1255628020
$4,542.41
in general payments reported to CMS, 2019-2025
11 companies · $466 in 2025
The $466 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $80.81 · 2022: $2,032 · 2023: $1,615 · 2024: $349 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,789 · Travel and Lodging: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,788.91 |
| Travel and Lodging | $640.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,110.93 | 2020-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Pain Management |
| Abbott Laboratories | $660.81 | 2022 | |
| Medtronic, INC. | $399.27 | 2022-2023 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $136.37 | 2023 | Relistor |
| Spr Therapeutics, INC | $68.18 | 2024 | Sprint Pns System |
| Nalu Medical, INC. | $61.20 | 2022 | |
| Avanos Medical | $34.00 | 2022 | |
| Stryker Corporation | $22.15 | 2023 | Neptune |
| Si-Bone, INC. | $20.91 | 2025 | |
| Grt US Holding, INC. | $15.28 | 2022 | |
| Curonix LLC | $13.31 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lutz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.